Startpagina Podcasts EADV Podcast
EADV Podcast

EADV Podcast

EADV 177 Afleveringen okt. 9, 2026

The EADV Podcast presents the newest research in dermatology and venereology, produced by the European Academy of Dermatology and Venereology. Episodes feature interviews with notable doctors, professors and researchers from across the field. It offers a focused look at today's dermatology practice alongside emerging developments and how they may shape the future. Discussions are aimed at clinicians and researchers who want concise updates on scientific advances.

Afleveringen

JP2610 | Editor’s Picks October 2026
JP2610 | Editor’s Picks October 2026 okt. 9, 2026 312 Join Prof. Christian Posch as he presents his selection of Editor’s Picks from the October 2026 issue:    Fewer dermatologists = later-stage melanomas JAK-STAT inhibitors and infection risk Marriage as a survival factor in metastatic Merkel cell carcinoma Simulated daylight PDT: pain-free but not powerful enough for actinic keratoses?   Read the Editor's Picks here: https://doi.org/10.1111/jdv.7
JD2609 | Severe Drug Reactions: When a Pill Turns the Immune System Against the Skin
JD2609 | Severe Drug Reactions: When a Pill Turns the Immune System Against the Skin sep. 22, 2026 1835 In this episode of the EADV Podcast, Dr. Sarah Walsh is joined by Dr. Saskia Oro (Henri Mondor Hospital, Paris) and Dr. Emmanuel Contassot (University of Basel) to mark the launch of the new EADV CARD-EM Task Force. The conversation opens with the newly published European expert consensus on the diagnosis and management of acute generalised exanthematous pustulosis (AGEP), including how to identif
JT2609 | Takeaway September 2026
JT2609 | Takeaway September 2026 sep. 14, 2026 390 In this JEADV Takeaway, Dr. Stefania Guida takes you through "Sex disparities in melanoma stage, recurrence and mortality: A Danish cohort study, 2004 to 2024" by J. E. Lyngstrand et al., published in the September 2026 issue of JEADV. The full article is available here: https://doi.org/10.1111/jdv.70180
JP2609 | Editor’s Picks September 2026
JP2609 | Editor’s Picks September 2026 sep. 4, 2026 340 Join Prof. Carle Paul as he presents his selection of Editor’s Picks from the September 2026 issue:  Dose reduction of biologics in psoriasis: giving more freedom to patients Litifilimab for cutaneous lupus erythematosus Managing high impact-site psoriasis: an oral IL-23 Receptor inhibitor on the menu Comorbidities influence treatment response to immune checkpoint inhibitors in squamous-cell carc
EDU2608 | Melanoma Diagnosis: Why Dermoscopy Still Leads the Way
EDU2608 | Melanoma Diagnosis: Why Dermoscopy Still Leads the Way aug. 18, 2026 1162 In this episode of the EADV Podcast, held on behalf of the EADV Melanoma Task Force, Prof. Monika Arenbergerova is joined by Prof. Zoe Apalla and Prof. Aimilios Lallas to discuss the central role dermoscopy continues to play in melanoma diagnosis. The conversation opens with the newly published International Dermoscopy Society consensus recommendations for the management of lentigo maligna, explor
JT2608 | Takeaway August 2026
JT2608 | Takeaway August 2026 aug. 10, 2026 408 In this JEADV Takeaway, Dr. Prajwal Pudasaini takes you through "Addiction and chronic skin diseases: A Pan-European study on prevalence, associations and patient impact" by Ziehfreund S et al., published in the August 2026 issue of JEADV. The full article is available here: https://doi.org/10.1111/jdv.70245
JP2608 | Editor’s Picks August 2026
JP2608 | Editor’s Picks August 2026 aug. 7, 2026 313 Join Prof. Dr. Emek Kocatürk as she presents her selection of Editor’s Picks from the August 2026 issue:    Exosomes in dermatology: hype, hope and evidence CSU: the family burden behind the flare The eczema that was not: CTCL red flags before dupilumab Amivantamab-associated dermatologic toxicities: watch for ulcerative lesions   Read the Editor's Picks here: https://doi.org/10.1111/jdv.70558
EDU2607 | Hair Diseases and Alopecia: Insights from the EADV Hair Diseases Task Force
EDU2607 | Hair Diseases and Alopecia: Insights from the EADV Hair Diseases Task Force jul. 21, 2026 1226 In this episode of the EADV Podcast, Prof. Michela Starace, Chair of the EADV Hair Diseases Task Force, is joined by Task Force Co-Chairs Prof. Alexander Katoulis and Dr. Matilde Iorizzo to discuss current perspectives on scarring alopecias and the challenges of diagnosis and management. The conversation explores the relationship between lichen planopilaris and frontal fibrosing alopecia, highligh
JT2607 | Takeaway July 2026
JT2607 | Takeaway July 2026 jul. 13, 2026 391 In this JEADV Takeaway, Dr. Willemijn Witkam takes you through "Healthy plant-based dietary pattern is associated with a lower risk of rosacea" by Zhang et al., published in the July 2026 issue of JEADV. The full article is available here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70163
JP2607 | Editor’s Picks July 2026
JP2607 | Editor’s Picks July 2026 jul. 3, 2026 356 Join Prof. Carle Paul  as he presents his selection of Editor’s Picks from the July 2026 issue:  An expert consensus on treat-to-target criteria for chronic prurigo Evidence-based European guidelines for the treatment of acne Denifanstat for moderate to severe acne: a potential alternative to isotretinoin? JAK inhibitors for non-infectious granulomatous skin diseases Read the Editor's Picks here
JD2606 | LGBTQI+ Care in Dermatology & Venereology
JD2606 | LGBTQI+ Care in Dermatology & Venereology jun. 23, 2026 2795 In this special Pride Month episode of the EADV Podcast, Dr. Tiago Matos and Prof. Myrto Trakatelli explore why inclusion, visibility, and affirming care matter in dermatology and venereology today more than ever. Through an open and honest conversation, they discuss how everyday clinical interactions, communication, and representation can directly influence patient trust, healthcare access, and l
JP2606 | Editor’s Picks June 2026
JP2606 | Editor’s Picks June 2026 jun. 5, 2026 448 Join Prof. Rolland Gyulai as he presents his selection of Editor’s Picks from the June 2026 issue:    First oral TNFR1 inhibitor for mild-to-moderate psoriasis Adjuvant treatment with immune checkpoint inhibitors - no benefit in acral melanomas Simple biomarkers predict favourable treatment response Mogamulizumab-associated rash – new insights into pathogenesis Read the Editor's Picks here: http

Aanbevolen